Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
NCT05524298 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2026-01-12
Summary
Aims of this study are to describe the variation of QoL (Quality of Life) during the clinical management of low-grade lymphoma in elderly subjects and to identify the most important factors at diagnosis and during treatment with an impact on QoL (Quality of Life).
Conditions
- Low Grade Non-Hodgkin's Lymphoma, Adult
Sponsors & Collaborators
-
Fondazione Italiana Linfomi - ETS
lead OTHER
Principal Investigators
-
Salvatrice Mancuso · Ematologia - A.O.U. Policlinico Giaccone, Palermo
Eligibility
- Min Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-07
- Primary Completion
- 2026-02-28
- Completion
- 2026-02-28
Countries
- Italy
Study Locations
More Related Trials
-
Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors
NCT05934084 ·Status: RECRUITING ·Phase: NA
-
Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma
NCT04113226 ·Status: UNKNOWN ·Phase: PHASE2
-
Elderly Hodgkin Lymphoma Patients Treated With Chemoradiotherapy
NCT03535948 ·Status: UNKNOWN
-
Multidimensional Assessment of Quality of Life, Social and Professional Life and Care Utilization in Patients With Diffuse Large Cell B-cell Lymphoma Treated With CAR-T Cells
NCT05532761 ·Status: UNKNOWN
-
Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell Therapy in Real Life
NCT06026644 ·Status: ACTIVE_NOT_RECRUITING
-
Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era
NCT00902434 ·Status: COMPLETED
-
Application of Telemedicine to the Management of Aggressive Lymphomas
NCT03336138 ·Status: COMPLETED ·Phase: NA
-
Quality of Life Among Survivors of Hodgkin Lymphoma
NCT00598728 ·Status: COMPLETED
-
Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients
NCT00949741 ·Status: COMPLETED
-
Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH
NCT05600959 ·Status: NOT_YET_RECRUITING
-
Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission
NCT04298619 ·Status: COMPLETED
-
A Phase II Study of the FIL on Elderly Frail Patients With DLBCL
NCT02955823 ·Status: COMPLETED ·Phase: PHASE2
-
Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma
NCT02313389 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of the Relationship Between Anti-PD-1 Exposure and Tumour VOLUME in Patients Treated for Classical HODgkin's Lymphoma.
NCT04621604 ·Status: TERMINATED ·Phase: NA
-
Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma
NCT02555267 ·Status: COMPLETED
-
A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
NCT06008691 ·Status: RECRUITING
-
Study of Epigenetic and Inflammatory Markers of Accelerated Biological Ageing in the Follow up of Patients With Hodgkin's Lymphoma
NCT06761274 ·Status: RECRUITING ·Phase: NA
-
Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma
NCT00903890 ·Status: COMPLETED
-
Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy
NCT01829958 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Italian Study of Patients With Lymphoma
NCT06814925 ·Status: RECRUITING
-
Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL
NCT00209209 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi
NCT05929222 ·Status: RECRUITING ·Phase: PHASE3
-
Multicenter Retrospective Observational Study of Relapsed Diffuse Large B-Cell Lymphoma Presenting as Indolent Lymphoma
NCT06822829 ·Status: RECRUITING
-
Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen
NCT01478269 ·Status: COMPLETED
-
Causes of Death in Follicular Lymphoma: a Single Center Retrospective Analysis
NCT02951871 ·Status: COMPLETED